Aberdeen Group
ASMB icon

Aberdeen Group’s Assembly Biosciences ASMB Stock Holding History

Aberdeen Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69M Buy
+207,047
New +$5.64M 0.01% 678

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Aberdeen Group's ASMB Position: Q2 2026 in Review

Aberdeen Group opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 207,047 shares worth $5.69M. The stake represents 0.01% of the portfolio and ranks #678 among its holdings.

15 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Aberdeen Group held 207,047 shares of Assembly Biosciences worth $5.69M as of Q2 2026.
  • Assembly Biosciences was a new Aberdeen Group position in Q2 2026.
  • Assembly Biosciences made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #678 holding.
  • 15 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.